Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Re

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Tumori|December 31, 1994
An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancerA D Leo, L Biganzoli, S Bohm, et al.
Oncology|August 26, 1999
Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinomaS Böhm, S Oriana, G Spatti, et al.
Cancer|October 1, 1977
Lymphangiography in patients with ovarian epithelial cancer: an evaluation of 289 consecutive casesR Musumeci, A Banfi, G Bolis, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group StudyC F de Oliveira, A J Lacave, C Villani, et al.
Tumori|March 1, 1975
[Study of the retroperitoneal lymphatic spread of müllerian ovarian carcinoma, using lymphography]R Musumeci, A Banfi, G B Candiani, et al.
American Journal of Obstetrics and Gynecology|August 1, 1982
Natural history of dysgerminomaG De Palo, S Pilotti, R Kenda, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Tumori|December 31, 1994
An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancerA D Leo, L Biganzoli, S Bohm, et al.
Oncology|August 26, 1999
Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinomaS Böhm, S Oriana, G Spatti, et al.
Cancer|October 1, 1977
Lymphangiography in patients with ovarian epithelial cancer: an evaluation of 289 consecutive casesR Musumeci, A Banfi, G Bolis, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Randomized comparison of cyclophosphamide, doxorubicin and cisplatin (CAP) versus cyclophosphamide and doxorubicin (CA) for the treatment of advanced ovarian cancer (ADOVCA). A EORTC Gynecological Cancer Cooperative Group StudyC F de Oliveira, A J Lacave, C Villani, et al.
Tumori|March 1, 1975
[Study of the retroperitoneal lymphatic spread of müllerian ovarian carcinoma, using lymphography]R Musumeci, A Banfi, G B Candiani, et al.
American Journal of Obstetrics and Gynecology|August 1, 1982
Natural history of dysgerminomaG De Palo, S Pilotti, R Kenda, et al.
Pageof 4